<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival rate for 674 patients with LSCC. (<b>C</b>) Overall survival rate for HPV-positive (n = 33) and HPV-negative (n = 641) patients (P = 0.30). (<b>D</b>) Progression-free survival rate for HPV-positive (n = 33) and HPV-negative (n = 641) patients (P = 0.37).</p
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>The patients were stratified by the number of metastatic lymph nodes (A), the lymph node ratio (B...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>A) HPV<sup>+</sup>TSCC and B) HPV<sup>−</sup>TSCC patients stratified by the number of CD8<sup>+<...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p
The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>(A) Overall survival data for MDS patients stratified by <i>IDH1/2</i> mutational status. (B) Leu...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>The patients were stratified by the number of metastatic lymph nodes (A), the lymph node ratio (B...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>A) HPV<sup>+</sup>TSCC and B) HPV<sup>−</sup>TSCC patients stratified by the number of CD8<sup>+<...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p
The Kaplan–Meier curves for progression-free survival of cervical cancer patients based on LANR.</p
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>(A) Overall survival data for MDS patients stratified by <i>IDH1/2</i> mutational status. (B) Leu...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
<p>The patients were stratified by the number of metastatic lymph nodes (A), the lymph node ratio (B...